Friday 6 November 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue: +8.79%
EPS: +12.8%
Free cash flow: +43.6%
Total debt: −0.21%

Quarter to September 2026, against a year earlier

252.70 1.42 −0.56%

Follow STE

Alert me

Market cap: $24.8B
P/E: 30.0×
Fwd P/E: 25.1×
Dividend yield: 1.02%
F-score: 9/9
Altman Z: 5.10
Beneish M: −2.68
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Valuation Filings

STERIS plc 10-Q filed Nov 5, 2026

Fiscal Q2 2027 · Period ended Sep 30, 2026 · Filed Nov 5, 2026 · accepted 4:04 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Nov 6, 2025: 19 added · 20 removed · 66 modified; 17 with only figures updated

STERIS plc 10-Q filed Nov 5, 2026

What changed

Stockrow Weekly